-
News | 2023.02.20
Earthquake in Turkey: the Institut Pasteur sends scientists to support the relief effort
On a visit to the Institut Pasteur, Chrysoula Zacharopoulou, French Minister of State attached to the Minister for Europe and Foreign Affairs, welcomed the Institut Pasteur's decision to send scientists to help with the relief effort following the earthquake in Turkey. In April 2023, Turkey withdrew its request for assistance to the World Health Organization (WHO) for the deployment of...
-
News | 2023.06.21
Malaria: parasite migration strategy revealed
Malaria is a disease transmitted by mosquitoes that are vectors of parasites in the genus Plasmodium. Scientists from the Institut Pasteur, in collaboration with specialized physicists in Brazil and Germany, have elucidated the search strategy used by parasites to reach the bloodstream.
-
News | 2022.02.16
COVID-19: reducing outbreak risk with repeated antigen screening in healthcare facilities
With the emergence of the Omicron variant, healthcare facilities remain highly vulnerable to virus spread. Effective surveillance of viral presence in these facilities is therefore crucial and needs to be adapted according to outbreak risk. Scientists from the Institut Pasteur worked with colleagues to analyze the reactive use of antigen testing in a long-term care facility following a detected...
-
Article | 2024.04.30
Paul-Louis Simond, world traveler working on multiple diseases
A French naval medical officer, Paul-Louis Simond traveled the world and studied many diseases. After heading up a leprosarium in French Guiana from the age of 24, he spent several years in Indochina where he battled smallpox, and then in China.
-
Document de presse | 2024.05.28
AFROSCREEN: a key network for genomic surveillance in Sub-Saharan Africa
Three years after its launch, AFROSCREEN meets all its objectives, developing effective genomic surveillance to tackle epidemics in sub-Saharan Africa The AFROSCREEN project, financed to the tune of €10 million by Agence Française de Développement (AFD), has been working since 2021 to set up or strengthen sequencing platforms and build an operational network for monitoring emerging...
-
News | 2024.11.04
A novel method for producing DNA-based therapies
Scientists have combined enzyme and chemical techniques to develop an innovative method for producing synthetic DNA molecules. This novel approach opens up many new possibilities, especially for the production of large molecules that can be used for future therapies.
-
Fiche maladie | 2015.10.06
Aspergillosis
Aspergillosis is a general term for infections caused by a type of mold (fungus) belonging to the genus Aspergillus. The mold that causes aspergillosis can be found everywhere in the environment in the form of spores, but in certain conditions it can become pathogenic, for example in immunocompromised people or those with chronic lung disease. The diseases caused by Aspergillus differ depending...
-
Document de presse | 2025.02.28
Bpifrance and the Institut Pasteur strengthen cooperation to support launch of startups based on research
On February 27, 2025, Yasmine Belkaid, President of the Institut Pasteur, and Nicolas Dufourcq, CEO of Bpifrance, signed a cooperation agreement aimed at using their resources and skills to improve the transfer to industry of research results. This strategic partnership is designed to encourage the emergence of startups and innovative projects based on the Institut Pasteur’s research. It follows...
-
News | 2023.05.23
Creation of an European Biocluster for Emerging Infectious Diseases
The project "Infectious Diseases Cluster" (IDCluster) has been selected for the Healthcare Innovation 2030 plan. This strategy aims to strengthen biomedical research in France. Coordinated by Lyonbiopôle and supported by the Auvergne-Rhône-Alpes region, this European-scale cluster aims to accelerate progress in the field of emerging diseases, by working with the Institut Pasteur among others.
-
Article | 2019.05.21
Antimicrobial resistance
Antimicrobial resistance is dramatically increasing worldwide and is becoming one of the most urgent public health threats. There is an urgent need for actions to reverse the curve of antimicrobial resistance dissemination and to develop innovative drugs (antibiotics, antiparasitic, antifungals, antivirals, antivectors) and therapeutic strategies for safer and sustainable treatments of infectious...